You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PTGX Sale Disclosure
Ali Asif · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$1.79M
Ali Asif Chief Financial Officer
PTGX
Transaction date
Sep 30, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 2 days later
PTGX daily price context
Close on/before transaction
$140.89
Sep 30, 2026
First close after public filing
$140.63
Oct 5, 2026
30-day return after filing
-0.9%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 12,595 shares @ $141.77
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001104659-26-113279
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$9.7M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 30, 2026 | $359.75K |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 30, 2026 | $666.02K |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 30, 2026 | $300.32K |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 30, 2026 | $64.65K |
| Protagonist Therapeutics, Inc PTGX Current | Sale | Sep 30, 2026 | $1.79M |
| Protagonist Therapeutics, Inc PTGX | Sale | Sep 30, 2026 | $6.53M |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 30, 2026 | $0 |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 30, 2026 | $0 |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 30, 2026 | $0 |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 30, 2026 | $0 |